glp-1 and heart health drugs are changing more than the number on the scale. From diabetes obesity to heart, kidney, and metabolic — this story is getting bigger fast. ❤️ Swipe to learn How GLP-1 Medications Reduce Heart

Dokkyo J Med Sci

Maybe you saw Mounjaro mentioned somewhere and

Boosts Energy Levels The enzyme helps your body turn fat into fuel

The RSSDI Treatment Ladder, In Plain Language Step one: lifestyle change plus metformin for most newly diagnosed adults [1] Step two: if HbA1c is still above target after about three months, a second medicine is added rather than delayed Step three: the choice of that second medicine depends on your risk profile heart disease, kidney disease, or obesity push the decision towards a GLP-1 receptor agonist or an SGLT2 inhibitor [2] Step four: insulin is brought in when oral and injectable non-insulin options are not enough, and it can later be reduced if a GLP-1 drug is added Who Is Most Likely To Benefit From Adding A GLP-1

Pantothenic Acid (B-5): 10mg (200% DV)

PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313), mapping your response across 14 metabolic pathways and 49 peptides